Every time you buy a can of FlowBlend you are helping to improve Mental Health and heal the world.
FlowBlends mission is to reduce suffering and inspire a joy filled empowered life with unique products that elevate life experience. We believe every human being deserves a chance to heal old wounds, and pursue their own personal greatness in whatever way suits them best.
That is why we are excited to announce that starting December 1st 2021, 50¢ from every can sold on the FlowBlend website will be donated directly to the Multidisciplinary Association for Psychedelic Studies (MAPS).
In May of 2021, MAPS Phase 3 clinical trials for MDMA-assisted therapy for PTSD were published by Nature Medicine, one of the top scientific journals across fields. The results were fantastic, and the results represent a potential breakthrough treatment for PTSD. Phase 3 is the final stage before seeking FDA approval for a new prescription treatment.
If successful, this treatment could transform the lives of millions of people who live with the impacts of complex trauma.
(Copied From MAPS Website)
What MAPS is.
MAPS has been dedicated to psychedelic research since 1986. Now, they’re shifting perceptions to give medicine and our society the tools needed to heal—no matter who you are.
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit organization specializing in research and education that develops medical, legal, and cultural shifts benefiting the careful uses of psychedelics and marijuana for mental and spiritual healing.
In other words, we’ve dedicated the last 35 years to changing the way people think of, talk about, and consume psychedelics through research, education, and advocacy.
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
MAPS further their mission by:
- Developing psychedelics and marijuana into prescription medicines
- Educating the public honestly about the risks and benefits of psychedelics and marijuana.
- Supporting scientific research into spirituality, creativity, and neuroscience
- Training therapists and working to establish a network of treatment centers
We envision a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.
Transparency — Information is shared openly and clearly. Communications are respectful, honest, and forthright.
Passion and Perseverance — We persist in the face of challenges. We have a sense of urgency about our work, and know that it's a long-term effort.
Intelligent Risk — Our decisions are informed by research. We try new things and learn from our mistakes.
Trust and Accountability — We value integrity and honesty, and embrace high standards.
Learn more about MAPS HERE